Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CME Group Inc. (CME.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-28236.53267.00Buy
2022-03-03240.82275.00Buy
2022-04-04234.59269.00Buy
2022-04-29219.34284.00Buy
2022-06-03200.00258.00Buy
2022-07-06203.96246.00Buy
2022-08-01195.75240.00Buy
2022-09-02194.69237.00Buy
2022-10-04182.13221.00Buy
2022-10-28174.75226.00Buy
2023-01-04170.08220.00Buy
2023-04-04193.04230.00Buy
2023-10-26215.43250.00Buy
2024-10-02223.57275.00Buy
2025-02-13250.11290.00Buy
2025-04-24263.27305.00Buy

Disclosures

  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.